InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: turks post# 12300

Thursday, 09/28/2017 11:56:44 AM

Thursday, September 28, 2017 11:56:44 AM

Post# of 16886
There could be some interesting partnerships coming up...

We don't know much, but I would guess they are doing some cooperative research based on a joint development agreement. If the research pans out, they will enter into a license.

This solves the mystery of the feasibility study for a "mu opioid receptor antagonist" listed in TTNP's most recent corporate presentation. Basically, this is a six month (or maybe even one year) implant of naltexetone (e.g. Vivitrol).

Now, as for the kappa opioid receptor agonist for neuropathic pain also mentioned as being in a feasibility study, I bet they are partnering with someone on that as well.

Same with liraglutide (Victoza) for type 2 diabetes,

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News